Richard J. Lewis
University of Queensland
605 Papers
4.6K Citations
Richard J. Lewis is an academic researcher from University of Queensland. The author has contributed to research in topics: Chemistry & Conotoxin. The author has an hindex of 83, co-authored 545 publications. Previous affiliations of Richard J. Lewis include Fisons & University of Oxford.
Chat about Author
Papers
Pain management in older adults: facts to consider.
Alok Kumar Paul,Richard J. Lewis +1 more
TL;DR: Paul et al. as discussed by the authors investigated the role of pain in the development of pain management in the context of pharmacology and applied it to the field of cancer pain management, and found that pain management can improve the performance of cancer patients.
3
•Journal Article
Characterization and crystallisation of the malate dehydrogenase from Streptomyces aureofaciens.
TL;DR: Structural-Function Relationships in the Tissue Inhibitors of Metalloprotemases and the Mechanism of inhibition of the human matrix metalloproteinase stromelysm 1 by TIMP 1 are studied.
3
The Role of Adsorbed Species in 1-Butene Isomerization: Parahydrogen-Induced Polarization NMR of Pd–Au Catalyzed Butadiene Hydrogenation
Weiyu Wang,Richard J. Lewis,Bintian Lu,Qiang Wang,Graham J. Hutchings,Jun Xu,Feng Deng +6 more
TL;DR: Parahydrogen-induced polarization NMR spectroscopy reveals that residual sulfur species and PVP ligands influence 1-butene isomerization and hydrogenation pathways in Pd-Au bimetallic nanoparticles, with sulfur removal enhancing isomerization and PVP inducing polarized signals.
3
Re-engineering the μ-conotoxin SIIIA scaffold.
TL;DR: Unexpectedly, it appears that SIIIA loop 1 significantly influences its Nav channel interactions despite loop 2 and 3 residues constituting the pharmacophore, which may allow further development of selective NaV blockers.
3
•Journal Article
Drugs from the peptide venoms of marine cone shells.
TL;DR: Australian cone shell venoms are being investigated as an exciting new source of bioactive peptides as part of a new collaborative project between the 3D Centre and AMRAD to develop peptidomimetic drugs based on a selection of these native peptides.
3